Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new antiglycolytic agent.

C W le Roux1, S D Wilkinson, D V Pavitt

  • 1Department of Chemical Pathology, Charing Cross Hospital, London W6 8RF, UK. c.leroux@imperial.ac.uk

Annals of Clinical Biochemistry
|January 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors influencing patients to choose one obesity treatment over another: a qualitative study.

International journal of obesity (2005)·2025
Same author

Patient perceptions of success in obesity treatment: An IMI2 SOPHIA study.

Obesity science & practice·2024
Same author

Factors that determine patients considering medication for the disease of obesity: an IMI2 SOPHIA study.

International journal of obesity (2005)·2024
Same author

Simple tool to prioritize access to bariatric surgery for people living with obesity during the COVID-19 pandemic.

The British journal of surgery·2021
Same author

Remission and progression of pre-existing micro- and macroalbuminuria over 15 years after bariatric surgery in Swedish Obese Subjects study.

International journal of obesity (2005)·2020
Same author

Exaggerated postprandial GLP-1 secretion following esophagectomy is not associated with gastric emptying and intestinal transit.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2020
Same journal

Routine laboratory triage for NT-proBNP elevation may reflect cardiorenal frailty as much as heart failure specificity.

Annals of clinical biochemistry·2026
Same journal

From interpretable NT-proBNP prediction to equitable laboratory stewardship.

Annals of clinical biochemistry·2026
Same journal

Serum Sclerostin Levels in Children with Osteogenesis Imperfecta.

Annals of clinical biochemistry·2026
Same journal

Population-Specific HOMA-IR Reference Ranges in Iraq: Defining Insulin Sensitivity in a Middle Eastern Cohort.

Annals of clinical biochemistry·2026
Same journal

Optimizing Laboratory Quality with Sigma Metrics: Application of CLIA 2024 Total Allowable Error Guidelines.

Annals of clinical biochemistry·2026
Same journal

Suspected thermal amplitude of cryoglobulin likely more clinically significant than size detected: A case report.

Annals of clinical biochemistry·2026
See all related articles

A new blood collection tube additive combining glyceraldehyde, sodium fluoride, and potassium oxalate effectively prevents glucose degradation, ensuring accurate blood glucose measurements for up to 48 hours at room temperature.

Area of Science:

  • Clinical Chemistry
  • Biochemistry
  • Laboratory Medicine

Background:

  • Current glucose preservatives inadequately inhibit glycolysis, leading to significant glucose level drops (up to 0.5 mmol/L in 2-4 hours).
  • Immediate sample centrifugation is impractical, increasing the risk of misdiagnosis, particularly for diabetes based on fasting glucose levels.

Purpose of the Study:

  • To evaluate the efficacy of glyceraldehyde, alone and with standard antiglycolytic agents, in inhibiting glycolysis at room temperature over time.
  • To identify an improved method for preserving blood glucose stability in collected samples.

Main Methods:

  • Assessed glycolysis inhibition over time at room temperature using glyceraldehyde.
  • Tested combinations of glyceraldehyde with standard antiglycolytic agents (sodium fluoride and potassium oxalate).

Related Experiment Videos

Main Results:

  • Glyceraldehyde alone did not completely inhibit glycolysis.
  • A combination of 11 mmol/L glyceraldehyde, 119 mmol/L sodium fluoride, and 21.7 mmol/L potassium oxalate demonstrated optimal antiglycolytic performance.
  • Blood glucose values in samples stored for 48 hours at room temperature were comparable to those from immediately centrifuged samples, outperforming conventional methods.

Conclusions:

  • Blood samples collected in tubes containing glyceraldehyde, sodium fluoride, and potassium oxalate maintain glucose concentrations that accurately reflect in vivo levels.
  • This novel additive combination offers a clinically superior alternative for preserving blood glucose stability, mitigating diagnostic errors.